This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chapin, J. W. Articles by Snider, S. Search for Related Content PubMed Articles by Chapin, J. W. Articles by Snider, S. Social Bookmarking                   What's this?

Anesthesia for Renal Transplantation

University of Nebraska Medical Center, Department of Anesthesiolog, Omaha, NE

Nancy Bruda

University of Nebraska Medical Center, Department of Anesthesiolog, Omaha, NE

Sandra Snider

University of Nebraska Medical Center, Department of Anesthesiolog, Omaha, NE

Renal transplantation is the preferred mode of replace ment therapy for most patients with end-stage renal disease (ESRD) and accounts for nearly 60% of all organ transplants in the United States. While as many as 35,000 people remain on the list waiting to receive a cadaveric kidney, living-related renal transplantation offers a shorter waiting period and greater survival. Maximization of the health of the kidney recipient before transplantation can improve ultimate outcome. Proper anesthetic management is facilitated by under standing the physiology and pharmacology of ESRD. Maintaining intraoperative blood volume is a key to good graft function, especially the living-related pediat ric kidney recipient. Recent improvements in combined immnosuppression therapy have improved the overall outcome in transplant recipients. The average 3-year survival is nearly 75%.

Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 2, No. 2, 106-113 (1998)
DOI: 10.1177/108925329800200203


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?